A large number of CD8+ T cells continued to progress from central memory to terminal effect in the peripheral blood of patients with Parkinson’s disease (PD), and cytotoxic CD4+ T cells (CD4 CTLS) were significantly amplified from Th1 cells, providing valuable insights and rich resources for understanding adaptive immune responses in PD patients (40). Here, CD4 is linked to Parkinson disease.